ArticleThe European journal of neuroscience2016

Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.

Stephanie M Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.